George C. Clark
CIK 1878290 · VP, Chief Accounting Officer · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$981.1K
Companies
2
Total Filings
13
Lifetime Open-Market Net
-$1.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHVN | VP, Chief Accounting Officer | 86,978 | $11.28 | $981.1K | -$1.78M | 12 | 2026-03-03 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | VP, Chief Accounting Officer | 0 | — | — | $0 | 1 | 2022-10-03 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-07 | BHVN | Mixed | +944 | -$117.9K | EDGAR |
| 2021-12-22 | BHVN | Sell (S) | −1,915 | -$237.2K | EDGAR |
| 2021-11-26 | BHVN | Mixed | +4,597 | -$205.8K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.